ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Fast Track Designation granted to decompensated heart failure treatment
January 19, 2020The US FDA has granted Fast Track Designation to APD418, which is in development as treatment for decompensated heart failure patients. -
FDA Grants Fast Track Designation for Heart Failure Treatment
January 17, 2020Arena Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) granted Fast Track designation for APD418, a β3-adrenergic receptor (AdrR) antagonist and cardiac myotrope, in development for the treatment of decompensated heart failure (DHF).
Pharma Sources Insight January 2025
